{"index": 0, "id": "6f132291-8a44-47a8-9979-1d359c074a7c", "question": "Nerve supply of the mucosa of larynx, from epiglottis to the level of the cords is :", "options": {"A": "Superior laryngeal", "B": "External laryngeal", "C": "External laryngeal and recurrent laryngeal", "D": "Internal laryngeal and recurrent laryngeal"}, "gold": "A", "prediction": "D", "is_correct": false, "model_output": "To determine the nerve supply of the mucosa of the larynx from the epiglottis to the level of the vocal cords, we need to consider the innervation provided by the branches of the vagus nerve (cranial nerve X).\n\n1. **Superior Laryngeal Nerve (Option A):** The superior laryngeal nerve is a branch of the vagus nerve. It has two branches: the internal laryngeal nerve and the external laryngeal nerve. The internal laryngeal nerve provides sensory innervation to the mucous membrane of the larynx above the vocal cords, including the epiglottis. However, it does not innervate the area below the vocal cords.\n\n2. **External Laryngeal Nerve (Option B):** The external laryngeal nerve is another branch of the superior laryngeal nerve, primarily responsible for the motor innervation of the cricothyroid muscle, which is involved in adjusting the pitch of the voice. It does not provide sensory innervation to the mucosa of the larynx.\n\n3. **Recurrent Laryngeal Nerve (Option C):** The recurrent laryngeal nerve is also a branch of the vagus nerve. It provides both motor and sensory innervation. The sensory innervation of the mucosa below the vocal cords is provided by the recurrent laryngeal nerve. However, it is not responsible for the area above the vocal cords.\n\n4. **Internal Laryngeal and Recurrent Laryngeal (Option D):** The internal laryngeal nerve, as mentioned, supplies the mucosa above the vocal cords, including the epiglottis. The recurrent laryngeal nerve supplies the mucosa below the vocal cords. Together, they cover the entire mucosal area of the larynx from the epiglottis down to the level of the vocal cords.\n\nGiven the information, the correct answer is the combination of the internal laryngeal and recurrent laryngeal nerves, as they together provide the sensory innervation to the mucosa of the larynx from the epiglottis to the level of the vocal cords.\n\nSo, the answer is D.", "subject_name": "Anatomy", "inference_time_sec": 17.52297019958496, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:30:26.813769+00:00"}
{"index": 1, "id": "3513f98e-19a9-4dfd-8f49-1e8514c3907c", "question": "In the formula for urea clearance, C = U x V/P, what does U stands for:", "options": {"A": "Urinary concentration in g/24 hour", "B": "Urinary concentration in mg/ml", "C": "Urine osmolarity", "D": "Urine volume per minute"}, "gold": "B", "prediction": "B", "is_correct": true, "model_output": "To determine the correct answer, let's break down the formula for urea clearance, which is C = U x V/P, where C stands for clearance, U for the concentration of the substance in the urine, V for the urine flow rate, and P for the plasma concentration of the substance.\n\n1. **Understanding the components of the formula:**\n   - **C (Clearance):** This is the volume of plasma from which the substance is completely removed per unit time and is expressed in units of volume per time (e.g., mL/min).\n   - **U (Urine concentration):** This represents the concentration of the substance in the urine. It's crucial to note that this concentration should be in the same units as the plasma concentration (P) to allow for accurate calculation of clearance. For urea, which is often measured in blood in mg/dL, the urine concentration would ideally be in mg/mL.\n   - **V (Urine flow rate):** This is the volume of urine produced per unit time, usually measured in mL/min.\n   - **P (Plasma concentration):** This is the concentration of the substance in the plasma, which should match the units of U for the formula to be valid.\n\n2. **Evaluating the options:**\n   - A. **Urinary concentration in g/24 hour:** This option is incorrect because the units for clearance (C) are typically much smaller (e.g., mL/min), and using g/24 hour would not be appropriate for the calculation of clearance.\n   - B. **Urinary concentration in mg/ml:** This is the correct unit for U in the context of the formula. It allows for the calculation of clearance in a manner that is consistent with the units of plasma concentration (P) and urine flow rate (V).\n   - C. **Urine osmolarity:** Osmolarity is a measure of the concentration of osmotically active particles in a solution, expressed in osmoles per liter (Osm/L). While it's related to the concentration of substances in the urine, it's not what U represents in the clearance formula.\n   - D. **Urine volume per minute:** This is actually the definition of V (urine flow rate), not U.\n\n3. **Conclusion:** Based on the explanation, U in the formula for urea clearance stands for the urinary concentration of the substance, which should be in the same units as the plasma concentration for the formula to be valid. Therefore, the correct answer is the one that matches this description.\n\nAnswer: B.", "subject_name": "Physiology", "inference_time_sec": 18.108967781066895, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:30:44.936773+00:00"}
{"index": 2, "id": "caec1fed-b5cf-4aa1-98bd-0c0806992f06", "question": "Which of the following hormones will be affected most after the change in sex hormone binding globulin?", "options": {"A": "Testosterone", "B": "Estrogen", "C": "Progesterone", "D": "DHEA"}, "gold": "A", "prediction": "A", "is_correct": true, "model_output": "Sex hormone-binding globulin (SHBG) is a protein that binds to sex hormones, including testosterone and estradiol (a form of estrogen), in the blood. It plays a crucial role in regulating the levels of these hormones by binding to them and transporting them in the bloodstream, thereby influencing their bioavailability and activity.\n\nA. Testosterone: Testosterone is a primary androgen hormone, and a significant portion of it is bound to SHBG. Changes in SHBG levels can directly affect the amount of free (unbound) testosterone available in the body, which is the biologically active form. An increase in SHBG would decrease the amount of free testosterone, while a decrease in SHBG would increase the amount of free testosterone.\n\nB. Estrogen: Estrogen, particularly estradiol, is also bound to SHBG. However, the body can convert androgens (like testosterone) to estrogens through the action of the enzyme aromatase. Therefore, while changes in SHBG can affect estrogen levels indirectly, the direct impact is less pronounced compared to testosterone.\n\nC. Progesterone: Progesterone is a steroid hormone involved in the menstrual cycle and pregnancy. It is not primarily bound to SHBG. Instead, it is transported in the bloodstream bound to albumin and other proteins. Thus, changes in SHBG levels have a minimal direct effect on progesterone levels.\n\nD. DHEA (Dehydroepiandrosterone): DHEA is an androgen produced by the adrenal glands. It is not primarily bound to SHBG. DHEA can be converted to more potent androgens and estrogens in the body, but its levels are not directly influenced by SHBG.\n\nConsidering the above, the hormone most directly affected by changes in sex hormone-binding globulin (SHBG) levels is testosterone, as it is significantly bound to SHBG and its bioavailability is directly influenced by the levels of this protein.\n\nAnswer: A.", "subject_name": "Physiology", "inference_time_sec": 14.023284196853638, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:30:58.975519+00:00"}
{"index": 3, "id": "ddd74ca8-115f-444b-a754-28567fb618b1", "question": "Craniopagus is defined as fusion of:", "options": {"A": "Head and spine", "B": "Head only", "C": "Thorax and spine", "D": "Thorax only"}, "gold": "B", "prediction": "C", "is_correct": false, "model_output": "To answer this question, let's break down the definitions related to cranial and spinal fusions:\n\n1. **Craniopagus**: This term refers to a type of conjoined twinship where the twins are joined at the head. The prefix \"crani-\" comes from the Greek word for \"skull,\" indicating that the fusion involves the cranial region.\n\n2. **Spina bifida** or **spinal fusion** would refer to a condition affecting the spine, not the head. It's a congenital defect where there is incomplete closing of the backbone and membranes around the spinal cord.\n\n3. **Thoracopagus** refers to a type of conjoined twinship where the twins are joined at the chest (thorax).\n\nGiven these definitions:\n- Option A (Head and spine) is incorrect because craniopagus specifically refers to the head, not the spine.\n- Option B (Head only) is correct because craniopagus involves the fusion of the heads of conjoined twins.\n- Option C (Thorax and spine) is incorrect because this describes thoracopagus, not craniopagus.\n- Option D (Thorax only) is incorrect as it does not relate to craniopagus but rather to thoracopagus.\n\nSo, the correct answer is the one that specifies the fusion of the head only.", "subject_name": "Pediatrics", "inference_time_sec": 9.732369661331177, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:31:08.722146+00:00"}
{"index": 4, "id": "d8a284c5-175a-4439-8ef2-5ff24b41f3cc", "question": "A 30 year old female is on antibiotics with prolonged IV cannulation, has spike of fever, the likely cause is :", "options": {"A": "Pseudomonas aerugenosa", "B": "Coagulase negative staphylococcus", "C": "Streptococcus agalactiae", "D": "E. coli"}, "gold": "B", "prediction": "B", "is_correct": true, "model_output": "To approach this question, let's consider the key elements provided:\n\n1. **Prolonged IV cannulation**: This is a significant risk factor for developing infections, particularly those related to the skin and soft tissues. The longer the cannula is in place, the higher the risk of introducing bacteria into the bloodstream.\n\n2. **Spike of fever**: Fever is a common systemic response to infection. In the context of IV cannulation, it suggests that the infection is likely related to the site of the cannula or the IV line itself.\n\n3. **Common pathogens in IV line infections**: The most common pathogens associated with IV line infections include Staphylococcus species, particularly those that are coagulase-negative, and gram-negative bacteria like Pseudomonas aeruginosa. Coagulase-negative staphylococci (CoNS), such as Staphylococcus epidermidis, are part of the normal skin flora and are notorious for causing infections associated with indwelling medical devices, including IV lines.\n\n- **A. Pseudomonas aeruginosa**: While Pseudomonas aeruginosa is a common cause of hospital-acquired infections, it is more commonly associated with respiratory infections, particularly in immunocompromised patients or those with cystic fibrosis, and less commonly with IV line infections compared to CoNS.\n\n- **B. Coagulase-negative staphylococcus (CoNS)**: This is the most common cause of catheter-related bloodstream infections, especially in the context of prolonged IV cannulation. CoNS are part of the normal skin flora and can easily colonize the catheter.\n\n- **C. Streptococcus agalactiae (Group B Streptococcus)**: This bacterium is more commonly associated with infections in newborns, pregnant women, and individuals with certain underlying health conditions, rather than with IV line infections in otherwise healthy adults.\n\n- **D. E. coli**: While E. coli can cause a wide range of infections, it is less commonly associated with IV line infections compared to CoNS.\n\nGiven these considerations, the most likely cause of a fever in a patient with prolonged IV cannulation is an infection by Coagulase-negative staphylococcus, due to its prevalence in skin flora and its propensity to cause infections in the context of indwelling medical devices.\n\nAnswer: B.", "subject_name": "Microbiology", "inference_time_sec": 17.04514718055725, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:31:25.781360+00:00"}
{"index": 5, "id": "defe1c85-63fe-4a16-ba10-b3749975818a", "question": "The cribriform plate connects:", "options": {"A": "Nasal cavity and anterior cranial fossa", "B": "Nasal cavity and orbit", "C": "Nasal cavity and oral cavity", "D": "Anterior cranial fossa and orbit"}, "gold": "A", "prediction": "A", "is_correct": true, "model_output": "To determine the correct answer, let's analyze the anatomy of the skull, specifically focusing on the cribriform plate and its connections.\n\nThe cribriform plate is a part of the ethmoid bone, which is a spongy bone located at the roof of the nasal cavity. The ethmoid bone serves as a bridge between the nasal cavity and the cranial cavity. The cribriform plate is named for its sieve-like (cribriform) appearance due to the numerous small foramina (openings) it contains. These foramina allow the passage of the olfactory nerves (cranial nerve I) from the nasal cavity to the brain, enabling the sense of smell.\n\nNow, let's evaluate the options:\n\nA. Nasal cavity and anterior cranial fossa: This option correctly identifies the cribriform plate's role as a connection between the nasal cavity and the anterior cranial fossa, where the olfactory nerves transmit sensory information.\n\nB. Nasal cavity and orbit: The orbit is the bony cavity that contains the eye and its associated structures. The cribriform plate does not connect the nasal cavity to the orbit.\n\nC. Nasal cavity and oral cavity: The oral cavity is the space inside the mouth, and it is not directly connected to the nasal cavity by the cribriform plate.\n\nD. Anterior cranial fossa and orbit: While the anterior cranial fossa is correctly identified, the connection is specifically with the nasal cavity, not the orbit.\n\nGiven the information, the correct answer is the one that accurately describes the cribriform plate's connection between the nasal cavity and the anterior cranial fossa.\n\nAnswer: A.", "subject_name": "Anatomy", "inference_time_sec": 11.8040771484375, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:31:37.601395+00:00"}
{"index": 6, "id": "4e9a8341-05b8-4b00-859b-7a13d13b81a0", "question": "Which of the following headgear is preferred while treating a class II div. 1 malocclusion with a horizontal growth trend?", "options": {"A": "High pull head gear", "B": "Medium pull head gear", "C": "Cervical head gear", "D": "Reverse pull head gear"}, "gold": "C", "prediction": "C", "is_correct": true, "model_output": "To address a Class II division 1 malocclusion with a horizontal growth trend, we need to consider the type of headgear that will effectively counteract the excessive mandibular growth or promote maxillary growth to correct the malocclusion. Here's a brief overview of the options provided:\n\nA. High pull headgear: This type of headgear is used to apply a force to the upper teeth, pulling them backward and downward. It's more commonly used in cases where there is a need to correct a Class II malocclusion with a vertical growth pattern, as it can exacerbate a horizontal growth pattern.\n\nB. Medium pull headgear: This type of headgear is less commonly discussed in the literature and its specifics can vary, but generally, it's not the first choice for addressing a Class II division 1 malocclusion with a horizontal growth pattern.\n\nC. Cervical headgear: This type of headgear is applied to the cervical region of the head, pulling the maxilla forward and downward. It's particularly useful in cases where there is a need to correct a Class II malocclusion with a horizontal growth pattern, as it can effectively counteract the excessive mandibular growth and promote a more favorable growth pattern.\n\nD. Reverse pull headgear: This type of headgear is used to pull the mandible forward, which is not the desired effect in treating a Class II division 1 malocclusion, especially with a horizontal growth trend, as it would not correct the underlying issue of excessive mandibular growth.\n\nConsidering the need to correct a Class II division 1 malocclusion with a horizontal growth trend, the most appropriate headgear would be the one that can effectively counteract the excessive mandibular growth and promote a more favorable growth pattern. Cervical headgear is specifically designed to do this by pulling the maxilla forward and downward, which can help to correct the Class II relationship and address the horizontal growth pattern.\n\nSo, the answer is C.", "subject_name": "Dental", "inference_time_sec": 14.074675798416138, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:31:51.692386+00:00"}
{"index": 7, "id": "e2dd93d8-8047-4e9a-9389-e2b1781f8a35", "question": "Which is the most conspicuous sign in breast cancer?", "options": {"A": "Nipple retraction", "B": "Peau d'orange", "C": "Puckering", "D": "Cancer en-cuirasse"}, "gold": "B", "prediction": "A", "is_correct": false, "model_output": "To determine the most conspicuous sign in breast cancer, let's evaluate each option:\n\nA. Nipple retraction: This is a common symptom of breast cancer, particularly in cases where the cancer is located in the upper outer quadrant of the breast. The retraction occurs due to the pulling of the nipple and areola inward by the tumor. It's often noticeable and can be a significant indicator of malignancy.\n\nB. Peau d'orange (Skin of the orange): This term describes a condition where the skin of the breast looks like the skin of an orange, due to lymphedema (swelling) caused by a blockage in the lymphatic vessels. While it is a sign associated with breast cancer, it is not as immediately noticeable as nipple retraction and usually occurs in more advanced stages.\n\nC. Puckering: Puckering of the skin can be a sign of breast cancer, but it is less specific and can also be seen in benign conditions such as fibroadenomas or fibrocystic changes. It's not as distinctive or alarming as nipple retraction.\n\nD. Cancer en-cuirasse (Cancer en-cuirasse or \"in armor\"): This term describes a hard, thickened, and often immobile breast that resembles armor. It is a late sign of breast cancer, indicating a very advanced stage of the disease. It is not as immediately noticeable or as common as nipple retraction.\n\nConsidering the options, nipple retraction is the most conspicuous and specific sign of breast cancer, often prompting patients to seek medical attention and is frequently one of the first noticeable symptoms.\n\nAnswer: A.", "subject_name": "Surgery", "inference_time_sec": 11.478375911712646, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:32:03.185525+00:00"}
{"index": 8, "id": "6f1fdbc9-920f-4bff-b2eb-ba300fd9cc59", "question": "Which of these findings is not specific of blast injury?", "options": {"A": "Abrasion", "B": "Bruise", "C": "Puncture laceration", "D": "Fracture"}, "gold": "D", "prediction": "C", "is_correct": false, "model_output": "To determine which of the given options is not specific to a blast injury, let's analyze each option in the context of blast injuries:\n\nA. Abrasion: An abrasion is a superficial wound caused by the removal of the superficial layers of the skin, often due to friction or rubbing against a rough surface. In the context of a blast injury, an abrasion can occur due to flying debris or being thrown against a surface, making it a possible finding in blast injuries.\n\nB. Bruise: A bruise, or contusion, is caused by blood leakage into the tissues from damaged blood vessels. In a blast, the shockwave can cause blood vessels to rupture, leading to bruising. Thus, bruising can be a result of a blast injury.\n\nC. Puncture laceration: A puncture laceration is typically caused by a sharp object penetrating the skin. While it's possible for a blast to cause a puncture wound from flying debris, such as shrapnel, the term \"puncture laceration\" more commonly suggests a wound caused by a sharp, pointed object rather than the high-pressure shockwave associated with a blast.\n\nD. Fracture: A fracture is a break in a bone. Blast injuries can cause fractures due to the high-pressure shockwave that can shatter bones. The force from the blast can also cause indirect injuries, such as fractures, from being thrown or from the shockwave's impact on the body.\n\nConsidering the mechanisms of injury, a puncture laceration (C) is more specifically associated with a penetrating injury from a sharp object rather than the high-pressure shockwave and flying debris typically associated with a blast injury. While it's not impossible for a blast to cause a puncture wound, the term \"puncture laceration\" is less specific to the blast mechanism compared to the other options.\n\nSo, the answer is C.", "subject_name": "Forensic Medicine", "inference_time_sec": 13.417375564575195, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:32:16.618306+00:00"}
{"index": 9, "id": "3b150083-1a5e-49ef-bc36-41a06b677b32", "question": "Major aim of phase 1 clinical trials is:", "options": {"A": "Safety", "B": "Efficacy", "C": "Dose", "D": "Pharmacokinetics"}, "gold": "C", "prediction": "D", "is_correct": false, "model_output": "To approach this question, let's break down the phases of clinical trials and the primary objectives of each phase:\n\n1. **Phase 1 Clinical Trials**: These are the first stage of testing in human subjects and are primarily designed to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a drug. The main goals are to determine a safe dosage range and identify side effects.\n\n2. **Safety (A)**: While safety is a critical aspect of Phase 1 trials, it is not the only aim. Safety is a broad term that encompasses several aspects, including the identification of adverse effects, but it's not the most specific or comprehensive answer for the primary aim of Phase 1 trials.\n\n3. **Efficacy (B)**: Efficacy is the ability of a drug to produce the desired therapeutic effect. Efficacy is typically assessed in later phases of clinical trials, such as Phase 2 and 3, where the drug is tested in larger populations to see if it is effective for its intended use.\n\n4. **Dose (C)**: Determining the appropriate dose is a key part of Phase 1 trials. The goal is to find the maximum tolerated dose (MTD) and the recommended phase 2 dose (RP2D), which is the dose that is most likely to succeed in later stages of testing. This is closely related to the safety and pharmacokinetics of the drug.\n\n5. **Pharmacokinetics (D)**: Pharmacokinetics involves the study of how a drug is absorbed, distributed, metabolized, and excreted in the body. This is a critical component of Phase 1 trials, as understanding how the drug behaves in the body is essential for determining the appropriate dosage and dosing schedule.\n\nConsidering the above points, while all the options are relevant to Phase 1 trials, the most comprehensive and specific aim that encompasses the primary objectives of Phase 1 trials is the assessment of **pharmacokinetics** and **safety**. However, since the question asks for a single major aim and given that pharmacokinetics is a fundamental aspect of understanding how a drug behaves in the body, which is crucial for determining safety and efficacy, the best answer would focus on the core aspect that underlies the other objectives.\n\nSo, the best answer is **D. Pharmacokinetics**, with the understanding that safety is also a major concern and closely related to pharmacokinetics in Phase 1 trials.\n\nHowever, it's worth noting that in a more nuanced interpretation, safety (A) could be considered the overarching goal, as it encompasses the outcomes of pharmacokinetics, efficacy, and dose determination. But based on the options provided and the emphasis on a single major aim, pharmacokinetics is the most specific and direct answer.", "subject_name": "Pharmacology", "inference_time_sec": 19.746794939041138, "model": "HPAI-BSC/Llama3.1-Aloe-Beta-8B", "max_new_tokens": 1024, "seed": 42, "timestamp": "2026-01-12T12:32:36.379542+00:00"}
